Trials / Completed
CompletedNCT05149651
Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars
Clinical and Radiographic Outcomes of Pulpotomy of Primary Molars Using Totalfill® Bioceramic Root Repair Material -Fast Set Putty, and ProRoot White MTA®. A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- University Ghent · Academic / Other
- Sex
- All
- Age
- 3 Years – 9 Years
- Healthy volunteers
- Accepted
Summary
An experimental prospective double-blind, randomized clinical trial (RCT) with parallel design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and mineral trioxide aggregate (MTA®) as a control.
Detailed description
When a tooth decay is too deep and extended into the tooth pulp, then the tooth is not indicated to be treated with a filling. Therefore, removing the diseased pulp and then cover the rest with a suitable material is required. The Purpose of this study is to check the success of pulp treatment on deciduous molars with deep caries using 2 pulp treatment agents: (Totalfill® and MTA®). The use between the materials is randomly assigned. However, the use of the materials has no side effect or complications as it is a routine dental procedure. The participants are healthy children aged between 3 and 9 years old, and the study is taking place in Ghent University Hospital, Ghent, Belgium, and it is planned to be conducted in duration of 4 years, which include 20 months for participants recruitment. After placing the material, the tooth is restored with stainless steel crowns, and the participant was asked for follow up to check the tooth and to take dental x-ray every 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Totalfill | Totalfill® Bioceramic Root Repair Material -Fast Set Putty is a pre-mixed, bioactive calcium silicate cement which used as pulpotomy agent to treat extensive decayed tooth indicated for pulpotomy. |
| DRUG | MTA | ProRoot White MTA® is a bioactive calcium silicate cement which used as pulpotomy agent to treat extensive decayed tooth indicated for pulpotomy. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-12-31
- Completion
- 2020-12-31
- First posted
- 2021-12-08
- Last updated
- 2023-11-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05149651. Inclusion in this directory is not an endorsement.